April 10, 2017 / 9:11 PM / 3 months ago

BRIEF-OHR Pharmaceutical provides update on ongoing squalamine clinical trial in WET-AMD

1 Min Read

April 10 (Reuters) - OHR Pharmaceutical Inc:

* OHR Pharmaceutical provides update on ongoing squalamine clinical trial in Wet-Amd

* OHR Pharmaceutical Inc says company now fully funded through efficacy data from ongoing trial and into 2018

* OHR Pharmaceutical Inc says results from ongoing clinical trial in WET-AMD ( MAKO study) expected by end of calendar 2017 or early 2018 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below